DUBLIN, Aug. 28, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/z3rtg7/investigation) has announced the addition of the "Investigation Report on China's Quetiapine Market, 2010-2019" report to their offering.
Developed by AstraZeneca plc, quetiapine (under the trade name of Seroquel) is an important drug for the treatment of schizophrenia. Approved by CFDA to treat schizophrenia in 2000, quetiapine was listed in the Catalogue of Drugs for the Basic National Medical Insurance in 2014. Currently, local manufacturers of quetiapine are Hunan Dongting Pharmaceutical Co., Ltd and Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory, the former owning relevant patent for quetiapine compound according to CFDA.
Quetiapine developed fast after entering China, with sales value reaching CNY 116 million in 2013 and CNY 131 million in 2014 with a year-on-year growth of 12.93% and CAGR reaching 9.72% during the period of 2010-2014. With accelerating pace of life and increased life pressure, the incidence of mental disorder keeps going up, which fosters the vast demand for quetiapine in China. Currently, Hunan Dongting Pharmaceutical Co., Ltd, Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory and AstraZeneca plc occupy the majority of market share, among of which AstraZeneca plc. had the largest share of 78.50% for sales value in 2014. As local enterprises have a patented quetiapine compound and sold it at a relatively low price, their market share is expected to expand in the next few years.
Key Topics Covered:
1 Related Concepts of Quetiapine
2 Market Profile of Quetiapine in China
3 Survey on Sales Status of Quetiapine in China, 2010-2014
4 Survey on Market Share of Major Manufacturers of Quetiapine in China, 2010-2014
5 Survey on Dosage Forms of Quetiapine in China, 2010-2014
6 Reference Price of Quetiapine in Chinese Hospitals in 2014
7 Major Manufacturers of Quetiapine in Chinese Market, 2010-2014
8 Market Outlook of Quetiapine in China, 2015-2019
- AstraZeneca plc.
- Hunan Dongting Pharmaceutical Co., Ltd
- No.1 Pharmaceutical Factory
- Suzhou Pharmaceutical Group Co., Ltd.
For more information visit http://www.researchandmarkets.com/research/z3rtg7/investigation
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
SOURCE Research and Markets